Saturday, 26 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14486
Articles
Company
Drug
Changchun GeneScience’s GenSci120 Receives NMPA Approval for Rheumatoid Arthritis Trials
February 10, 2025
Company
Drug
CARsgen’s Allogeneic BCMA CAR-T Therapy Achieves sCR in First Patient
February 10, 2025
Company
Haisco Pharmaceutical Group Registers Delaware Subsidiary to Expand Global Operations
February 10, 2025
Company
Drug
Beijing Luzhu Submits BLA for LZ901 Herpes Zoster Vaccine to NMPA
February 10, 2025
Company
Drug
Hainan Boao Lecheng Pilot Zone Implements Baclofen Intrathecal Therapy
February 10, 2025
Company
Deals
Xtalpi Invests in Alternative Bio for Cancer and Inflammation Drugs
February 10, 2025
Policy / Regulatory
NMPA’s New Guidelines for Drug Registration Review
February 10, 2025
Policy / Regulatory
Shanghai’s Three-Year Plan to Boost Elderly Care Quality
February 10, 2025
Company
Drug
NMPA Approves Sinocelltech’s Finotonlimab for Head and Neck Cancer
February 10, 2025
Policy / Regulatory
Tianjin Municipality Boosts Biopharmaceutical Industry with New Measures
February 10, 2025
Company
Drug
Hansoh Pharma’s Uplizna Receives Priority Review for IgG4-RD Treatment
February 10, 2025
Policy / Regulatory
NMPA Seeks Public Feedback on Export Drug Manufacturing Rules
February 10, 2025
1
2
…
457
458
459
460
461
…
1,207
1,208
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?